1. Home
  2. SOPA vs THAR Comparison

SOPA vs THAR Comparison

Compare SOPA & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOPA
  • THAR
  • Stock Information
  • Founded
  • SOPA 2018
  • THAR 2017
  • Country
  • SOPA Singapore
  • THAR United States
  • Employees
  • SOPA N/A
  • THAR N/A
  • Industry
  • SOPA EDP Services
  • THAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOPA Technology
  • THAR Health Care
  • Exchange
  • SOPA Nasdaq
  • THAR Nasdaq
  • Market Cap
  • SOPA 3.8M
  • THAR 3.3M
  • IPO Year
  • SOPA 2021
  • THAR 2022
  • Fundamental
  • Price
  • SOPA $1.43
  • THAR $1.51
  • Analyst Decision
  • SOPA Strong Buy
  • THAR Strong Buy
  • Analyst Count
  • SOPA 1
  • THAR 1
  • Target Price
  • SOPA $15.00
  • THAR $17.00
  • AVG Volume (30 Days)
  • SOPA 177.7K
  • THAR 26.3K
  • Earning Date
  • SOPA 05-20-2025
  • THAR 05-12-2025
  • Dividend Yield
  • SOPA N/A
  • THAR N/A
  • EPS Growth
  • SOPA N/A
  • THAR N/A
  • EPS
  • SOPA N/A
  • THAR N/A
  • Revenue
  • SOPA $6,731,955.00
  • THAR N/A
  • Revenue This Year
  • SOPA N/A
  • THAR N/A
  • Revenue Next Year
  • SOPA N/A
  • THAR N/A
  • P/E Ratio
  • SOPA N/A
  • THAR N/A
  • Revenue Growth
  • SOPA N/A
  • THAR N/A
  • 52 Week Low
  • SOPA $0.64
  • THAR $0.95
  • 52 Week High
  • SOPA $6.75
  • THAR $6.39
  • Technical
  • Relative Strength Index (RSI)
  • SOPA 61.50
  • THAR 54.61
  • Support Level
  • SOPA $1.18
  • THAR $1.41
  • Resistance Level
  • SOPA $1.67
  • THAR $1.64
  • Average True Range (ATR)
  • SOPA 0.16
  • THAR 0.11
  • MACD
  • SOPA -0.00
  • THAR 0.01
  • Stochastic Oscillator
  • SOPA 60.00
  • THAR 63.86

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Share on Social Networks: